These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
270 related articles for article (PubMed ID: 15318939)
1. Osteopontin is a potential target gene in mouse mammary cancer chemoprevention by Se-methylselenocysteine. Unni E; Kittrell FS; Singh U; Sinha R Breast Cancer Res; 2004; 6(5):R586-92. PubMed ID: 15318939 [TBL] [Abstract][Full Text] [Related]
2. Se-methylselenocysteine activates caspase-3 in mouse mammary epithelial tumor cells in vitro. Unni E; Singh U; Ganther HE; Sinha R Biofactors; 2001; 14(1-4):169-77. PubMed ID: 11568454 [TBL] [Abstract][Full Text] [Related]
3. Se-methylselenocysteine inhibits phosphatidylinositol 3-kinase activity of mouse mammary epithelial tumor cells in vitro. Unni E; Koul D; Yung WK; Sinha R Breast Cancer Res; 2005; 7(5):R699-707. PubMed ID: 16168115 [TBL] [Abstract][Full Text] [Related]
4. Effects of methylselenocysteine on PKC activity, cdk2 phosphorylation and gadd gene expression in synchronized mouse mammary epithelial tumor cells. Sinha R; Kiley SC; Lu JX; Thompson HJ; Moraes R; Jaken S; Medina D Cancer Lett; 1999 Nov; 146(2):135-45. PubMed ID: 10656618 [TBL] [Abstract][Full Text] [Related]
5. Effect on an aqueous extract of selenium-enriched garlic on in vitro markers and in vivo efficacy in cancer prevention. Lu J; Pei H; Ip C; Lisk DJ; Ganther H; Thompson HJ Carcinogenesis; 1996 Sep; 17(9):1903-7. PubMed ID: 8824512 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of cdk2 kinase activity by methylselenocysteine in synchronized mouse mammary epithelial tumor cells. Sinha R; Medina D Carcinogenesis; 1997 Aug; 18(8):1541-7. PubMed ID: 9276628 [TBL] [Abstract][Full Text] [Related]
7. Characterization of the biological activity of gamma-glutamyl-Se-methylselenocysteine: a novel, naturally occurring anticancer agent from garlic. Dong Y; Lisk D; Block E; Ip C Cancer Res; 2001 Apr; 61(7):2923-8. PubMed ID: 11306469 [TBL] [Abstract][Full Text] [Related]
8. Selenium modulation of cell proliferation and cell cycle biomarkers in normal and premalignant cells of the rat mammary gland. Ip C; Thompson HJ; Ganther HE Cancer Epidemiol Biomarkers Prev; 2000 Jan; 9(1):49-54. PubMed ID: 10667463 [TBL] [Abstract][Full Text] [Related]
9. Chemopreventive doses of methylselenocysteine alter circadian rhythm in rat mammary tissue. Zhang X; Zarbl H Cancer Prev Res (Phila); 2008 Jul; 1(2):119-27. PubMed ID: 19122877 [TBL] [Abstract][Full Text] [Related]
10. Methylselenocysteine modulates proliferation and apoptosis biomarkers in premalignant lesions of the rat mammary gland. Ip C; Dong Y Anticancer Res; 2001; 21(2A):863-7. PubMed ID: 11396176 [TBL] [Abstract][Full Text] [Related]
11. Monomethylated selenium inhibits growth of LNCaP human prostate cancer xenograft accompanied by a decrease in the expression of androgen receptor and prostate-specific antigen (PSA). Lee SO; Yeon Chun J; Nadiminty N; Trump DL; Ip C; Dong Y; Gao AC Prostate; 2006 Jul; 66(10):1070-5. PubMed ID: 16637076 [TBL] [Abstract][Full Text] [Related]
12. Se-methylselenocysteine induces apoptosis through caspase activation and Bax cleavage mediated by calpain in SKOV-3 ovarian cancer cells. Yeo JK; Cha SD; Cho CH; Kim SP; Cho JW; Baek WK; Suh MH; Kwon TK; Park JW; Suh SI Cancer Lett; 2002 Aug; 182(1):83-92. PubMed ID: 12175527 [TBL] [Abstract][Full Text] [Related]
13. Se-methylselenocysteine induces apoptosis mediated by reactive oxygen species in HL-60 cells. Jung U; Zheng X; Yoon SO; Chung AS Free Radic Biol Med; 2001 Aug; 31(4):479-89. PubMed ID: 11498281 [TBL] [Abstract][Full Text] [Related]
14. Mechanisms of mammary cancer chemoprevention by organoselenium compounds. El-Bayoumy K; Sinha R Mutat Res; 2004 Jul; 551(1-2):181-97. PubMed ID: 15225592 [TBL] [Abstract][Full Text] [Related]
15. Se-methylselenocysteine induces apoptosis through caspase activation in HL-60 cells. Kim T; Jung U; Cho DY; Chung AS Carcinogenesis; 2001 Apr; 22(4):559-65. PubMed ID: 11285189 [TBL] [Abstract][Full Text] [Related]
16. Chemoprevention with triphenylselenonium chloride in selenium-deficient rats. Ip C; Lisk DJ; Ganther HE Anticancer Res; 2000; 20(6B):4179-82. PubMed ID: 11205245 [TBL] [Abstract][Full Text] [Related]
17. Chemical form of selenium, critical metabolites, and cancer prevention. Ip C; Hayes C; Budnick RM; Ganther HE Cancer Res; 1991 Jan; 51(2):595-600. PubMed ID: 1824684 [TBL] [Abstract][Full Text] [Related]
18. Selenium and mouse mammary tumorigenesis: an investigation of possible mechanisms. Medina D; Lane HW; Tracey CM Cancer Res; 1983 May; 43(5 Suppl):2460s-2464s. PubMed ID: 6403237 [TBL] [Abstract][Full Text] [Related]
19. Efficacy of increasing the therapeutic index of irinotecan, plasma and tissue selenium concentrations is methylselenocysteine dose dependent. Azrak RG; Cao S; Pendyala L; Durrani FA; Fakih M; Combs GF; Prey J; Smith PF; Rustum YM Biochem Pharmacol; 2007 May; 73(9):1280-7. PubMed ID: 17239826 [TBL] [Abstract][Full Text] [Related]
20. Chemoprevention of colon cancer by a glutathione conjugate of 1,4-phenylenebis(methylene)selenocyanate, a novel organoselenium compound with low toxicity. Rao CV; Wang CQ; Simi B; Rodriguez JG; Cooma I; El-Bayoumy K; Reddy BS Cancer Res; 2001 May; 61(9):3647-52. PubMed ID: 11325834 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]